speb/financial-data huggingface dataset:
CHCT income_statement (quarterly, 2025-12-31) — Gross Profit: 24932000.00
CHCT income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: -11803000.00
CHCT income_statement (annual, 2025-12-31) — Interest Expense: 26978000.00
CHCT income_statement (quarterly, 2025-12-31) — Interest Expense: 6959000.00
CHCT income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 26978000.00
CHCT income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 6959000.00
CHCT income_statement (annual, 2025-12-31) — Interest Income: 34000.00
CHCT income_statement (quarterly, 2025-12-31) — Interest Income: 19000.00
CHCT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 34000.00
CHCT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 19000.00
CHCT cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 25934000.00
CHCT cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 6702000.00
CHCT balance_sheet (annual, 2025-12-31) — Invested Capital: 961586000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 961586000.00
CHCT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -47696000.00
CHCT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -3996000.00
CHCT balance_sheet (annual, 2025-12-31) — Investment Properties: 922913000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Investment Properties: 922913000.00
CHCT cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
CHCT cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 0.00
CHCT cash_flow (annual, 2025-12-31) — Issuance Of Debt: 46000000.00
CHCT cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 2000000.00
CHCT balance_sheet (annual, 2025-12-31) — Line Of Credit: 258000000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Line Of Credit: 258000000.00
CHCT balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 3996000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 3996000.00
CHCT balance_sheet (annual, 2025-12-31) — Long Term Debt: 274199000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 274199000.00
CHCT balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 278195000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 278195000.00
CHCT cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 46000000.00
CHCT cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 2000000.00
CHCT cash_flow (annual, 2025-12-31) — Long Term Debt Payments: 0.00
CHCT cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: 0.00
CHCT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 0.00
CHCT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 0.00
CHCT balance_sheet (annual, 2025-12-31) — Net Debt: 528859000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Net Debt: 528859000.00
CHCT income_statement (annual, 2025-12-31) — Net Income: 5102000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Income: 14428000.00
CHCT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 2080000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 13684000.00
CHCT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 5102000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 14428000.00
CHCT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5102000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 14428000.00
CHCT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5102000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 14428000.00
CHCT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 5102000.00
CHCT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 14428000.00
CHCT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 5102000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 14428000.00
CHCT income_statement (annual, 2025-12-31) — Net Interest Income: -26944000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Interest Income: -6940000.00
CHCT cash_flow (annual, 2025-12-31) — Net Investment Properties Purchase And Sale: -32397000.00
CHCT cash_flow (quarterly, 2025-12-31) — Net Investment Properties Purchase And Sale: 2411000.00
CHCT cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 46000000.00
CHCT cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 2000000.00
CHCT cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 46000000.00
CHCT cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: 2000000.00
CHCT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -26944000.00
CHCT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -6940000.00
CHCT cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -2109000.00
CHCT cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
CHCT cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 5225000.00
CHCT cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 130000.00
CHCT balance_sheet (annual, 2025-12-31) — Net PPE: 3035000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Net PPE: 3035000.00
CHCT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 428080000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 428080000.00
CHCT balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 2947000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 2947000.00
CHCT income_statement (annual, 2025-12-31) — Normalized EBITDA: 65168000.00
CHCT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 14698000.00
CHCT income_statement (annual, 2025-12-31) — Normalized Income: -6299698.00
CHCT income_statement (quarterly, 2025-12-31) — Normalized Income: 246710.00
CHCT balance_sheet (annual, 2025-12-31) — Notes Receivable: 3830000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Notes Receivable: 3830000.00
CHCT cash_flow (annual, 2025-12-31) — Operating Cash Flow: 56430000.00
CHCT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 15500000.00
CHCT cash_flow (annual, 2025-12-31) — Operating Gains Losses: -11803000.00
CHCT cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -12051000.00
CHCT income_statement (annual, 2025-12-31) — Operating Income: 20266000.00
CHCT income_statement (quarterly, 2025-12-31) — Operating Income: 3440000.00
CHCT income_statement (annual, 2025-12-31) — Operating Revenue: 121195000.00
CHCT income_statement (quarterly, 2025-12-31) — Operating Revenue: 30946000.00
CHCT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 28471424.00
CHCT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 28471424.00
CHCT balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -379125000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -379125000.00
CHCT income_statement (annual, 2025-12-31) — Other Gand A: 25095000.00
CHCT income_statement (quarterly, 2025-12-31) — Other Gand A: 22978000.00
CHCT income_statement (annual, 2025-12-31) — Other Income Expense: 11803000.00
CHCT income_statement (quarterly, 2025-12-31) — Other Income Expense: 17951000.00
CHCT balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 1307000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 1307000.00
CHCT cash_flow (annual, 2025-12-31) — Other Non Cash Items: -3721000.00
CHCT cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: -985000.00
CHCT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 6416000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 6416000.00
CHCT balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 4216000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 4216000.00
CHCT balance_sheet (annual, 2025-12-31) — Other Properties: 3035000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Other Properties: 3035000.00
CHCT balance_sheet (annual, 2025-12-31) — Other Receivables: 7894000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Other Receivables: 7894000.00
CHCT income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 3022000.00
CHCT income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 744000.00
CHCT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 14925000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 14925000.00
CHCT balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CHCT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CHCT balance_sheet (annual, 2025-12-31) — Prepaid Assets: 1547000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Prepaid Assets: 1547000.00
CHCT income_statement (annual, 2025-12-31) — Pretax Income: 5125000.00
CHCT income_statement (quarterly, 2025-12-31) — Pretax Income: 14451000.00
CHCT income_statement (annual, 2025-12-31) — Provision For Doubtful Accounts: 8672000.00
CHCT income_statement (quarterly, 2025-12-31) — Provision For Doubtful Accounts: 0.00
CHCT cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 8672000.00
CHCT cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 0.00
CHCT cash_flow (annual, 2025-12-31) — Purchase Of Investment Properties: -64599000.00
CHCT cash_flow (quarterly, 2025-12-31) — Purchase Of Investment Properties: -28525000.00
CHCT balance_sheet (annual, 2025-12-31) — Receivables: 37296000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Receivables: 37296000.00
CHCT income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 22294000.00
CHCT income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 5589000.00
CHCT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 44868000.00
CHCT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 11239000.00
CHCT cash_flow (annual, 2025-12-31) — Repayment Of Debt: 0.00
CHCT cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: 0.00
CHCT balance_sheet (annual, 2025-12-31) — Retained Earnings: 90777000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 90777000.00
CHCT cash_flow (annual, 2025-12-31) — Sale Of Investment Properties: 32202000.00
CHCT cash_flow (quarterly, 2025-12-31) — Sale Of Investment Properties: 30936000.00
CHCT income_statement (annual, 2025-12-31) — Selling General And Administration: 25095000.00
CHCT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 10678000.00
CHCT balance_sheet (annual, 2025-12-31) — Share Issued: 28471424.00
CHCT balance_sheet (quarterly, 2025-12-31) — Share Issued: 28471424.00
CHCT income_statement (annual, 2025-12-31) — Special Income Charges: 11803000.00
CHCT income_statement (quarterly, 2025-12-31) — Special Income Charges: 17703000.00
CHCT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 14896000.00
CHCT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 2599000.00
CHCT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 429387000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 429387000.00
CHCT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 428080000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 428080000.00
CHCT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 401302.00
CHCT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 3769710.00
CHCT income_statement (annual, 2025-12-31) — Tax Provision: 23000.00
CHCT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.03
CHCT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
CHCT balance_sheet (annual, 2025-12-31) — Total Assets: 990757000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Total Assets: 990757000.00
CHCT balance_sheet (annual, 2025-12-31) — Total Capitalization: 703586000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 703586000.00
CHCT balance_sheet (annual, 2025-12-31) — Total Debt: 536195000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Total Debt: 536195000.00
CHCT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 429387000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 429387000.00
CHCT income_statement (annual, 2025-12-31) — Total Expenses: 100929000.00
CHCT income_statement (quarterly, 2025-12-31) — Total Expenses: 27506000.00
CHCT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 561370000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 561370000.00
CHCT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 943309000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 943309000.00
CHCT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 282411000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 282411000.00
CHCT income_statement (annual, 2025-12-31) — Total Unusual Items: 11803000.00
CHCT income_statement (quarterly, 2025-12-31) — Total Unusual Items: 17951000.00
CHCT income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 11803000.00
CHCT income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 17951000.00
CHCT balance_sheet (annual, 2025-12-31) — Working Capital: -231511000.00
CHCT balance_sheet (quarterly, 2025-12-31) — Working Capital: -231511000.00
CHCT income_statement (quarterly, 2026-03-31) — +Operating Expense: 15765000.00
CHCT income_statement (quarterly, 2026-03-31) — +Total Revenue: 31524000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 26175000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 719819000.00
CHCT cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 392000.00
CHCT cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 392000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Assets Held For Sale Current: 0.00
CHCT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 26991000.00
CHCT income_statement (quarterly, 2026-03-31) — Basic EPS: 0.07
CHCT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 3340000.00
CHCT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -4967000.00
CHCT cash_flow (quarterly, 2026-03-31) — Capital Expenditure Reported: -4967000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 3988000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 286000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2617000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2617000.00
CHCT cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -13666000.00
CHCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 13004000.00
CHCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -27467000.00
CHCT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 13740000.00
CHCT cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -591000.00
CHCT cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -972000.00
CHCT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -291000.00
CHCT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -1854000.00
CHCT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -723000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Common Stock: 286000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 421343000.00
CHCT income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 6369000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Current Assets: 41565000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Current Debt: 285000000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 285000000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Liabilities: 4986000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Current Deferred Revenue: 4986000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 306417000.00
CHCT cash_flow (quarterly, 2026-03-31) — Depreciation: 10657000.00
CHCT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 11049000.00
CHCT income_statement (quarterly, 2026-03-31) — Depreciation Amortization Depletion Income Statement: 10657000.00
CHCT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 11049000.00
CHCT income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 10657000.00
CHCT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 26991000.00
CHCT income_statement (quarterly, 2026-03-31) — Diluted EPS: 0.07
CHCT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 1774000.00
CHCT income_statement (quarterly, 2026-03-31) — EBIT: 9347000.00
CHCT income_statement (quarterly, 2026-03-31) — EBITDA: 20396000.00
CHCT cash_flow (quarterly, 2026-03-31) — End Cash Position: 2617000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Financial Assets: 7395000.00
CHCT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 13004000.00
CHCT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 8773000.00
CHCT cash_flow (quarterly, 2026-03-31) — Gain Loss On Investment Securities: 46000.00
CHCT income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: -46000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -392087000.00
CHCT income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 5108000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 1192000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 3012000.00
CHCT income_statement (quarterly, 2026-03-31) — Gross Profit: 25155000.00
CHCT cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 80000.00
CHCT income_statement (quarterly, 2026-03-31) — Interest Expense: 6799000.00
CHCT income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 6799000.00
CHCT income_statement (quarterly, 2026-03-31) — Interest Income: 3000.00
CHCT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 3000.00
CHCT cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 6534000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 980603000.00
CHCT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -27467000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Investment Properties: 947122000.00
CHCT cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 27000000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Line Of Credit: 285000000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 3988000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 274260000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 278248000.00
CHCT cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 27000000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Net Debt: 556643000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Income: 2548000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 1774000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 2548000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 2548000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 2548000.00
CHCT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 2548000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 2548000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Interest Income: -6796000.00
CHCT cash_flow (quarterly, 2026-03-31) — Net Investment Properties Purchase And Sale: -22650000.00
CHCT cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
CHCT cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 27000000.00
CHCT cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: 27000000.00
CHCT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -6796000.00
CHCT cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -330000.00
CHCT cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: 150000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Net PPE: 3012000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 420151000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 2753000.00
CHCT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 20442000.00
CHCT income_statement (quarterly, 2026-03-31) — Normalized Income: 2575600.00
CHCT balance_sheet (quarterly, 2026-03-31) — Notes Receivable: 3680000.00
CHCT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 13740000.00
CHCT cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 46000.00
CHCT income_statement (quarterly, 2026-03-31) — Operating Income: 9390000.00
CHCT income_statement (quarterly, 2026-03-31) — Operating Revenue: 31524000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 28571793.00
CHCT balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -392087000.00
CHCT income_statement (quarterly, 2026-03-31) — Other Gand A: 5108000.00
CHCT income_statement (quarterly, 2026-03-31) — Other Income Expense: -46000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1192000.00
CHCT cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -760000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 7054000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 4085000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Other Properties: 3012000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Other Receivables: 7833000.00
CHCT income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 774000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 16431000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CHCT balance_sheet (quarterly, 2026-03-31) — Prepaid Assets: 1260000.00
CHCT income_statement (quarterly, 2026-03-31) — Pretax Income: 2548000.00
CHCT cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
CHCT cash_flow (quarterly, 2026-03-31) — Purchase Of Investment Properties: -28514000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Receivables: 37688000.00
CHCT income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 5977000.00
CHCT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 11049000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 93325000.00
CHCT cash_flow (quarterly, 2026-03-31) — Sale Of Investment Properties: 5864000.00
CHCT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 5108000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Share Issued: 28571793.00
CHCT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 2711000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 421343000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 420151000.00
CHCT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -18400.00
CHCT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CHCT balance_sheet (quarterly, 2026-03-31) — Total Assets: 1010093000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 695603000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Total Debt: 563248000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 421343000.00
CHCT income_statement (quarterly, 2026-03-31) — Total Expenses: 22134000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 588750000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 968528000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 282333000.00
CHCT income_statement (quarterly, 2026-03-31) — Total Unusual Items: -46000.00
CHCT income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -46000.00
CHCT balance_sheet (quarterly, 2026-03-31) — Working Capital: -264852000.00
CHD balance_sheet (annual, 2021-12-31) — Commercial Paper: 249700000.00
CHD balance_sheet (annual, 2021-12-31) — Current Debt: 952200000.00
CHD balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 952200000.00
CHD balance_sheet (annual, 2021-12-31) — Foreign Currency Translation Adjustments: -30200000.00
CHD balance_sheet (annual, 2021-12-31) — Investmentsin Associatesat Cost: 9100000.00
CHD cash_flow (annual, 2021-12-31) — Issuance Of Debt: 799200000.00
CHD balance_sheet (annual, 2021-12-31) — Line Of Credit: 3100000.00
CHD cash_flow (annual, 2021-12-31) — Long Term Debt Issuance: 799200000.00
CHD balance_sheet (annual, 2021-12-31) — Minimum Pension Liabilities: -600000.00
CHD balance_sheet (annual, 2021-12-31) — Other Current Borrowings: 699400000.00
CHD income_statement (annual, 2022-12-31) — +Operating Expense: 1241200000.00
CHD income_statement (annual, 2022-12-31) — +Total Revenue: 5375600000.00
CHD balance_sheet (annual, 2022-12-31) — Accounts Payable: 666700000.00
CHD balance_sheet (annual, 2022-12-31) — Accounts Receivable: 422000000.00
CHD balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -840100000.00
CHD balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 366200000.00
CHD balance_sheet (annual, 2022-12-31) — Allowance For Doubtful Accounts Receivable: -3500000.00
CHD cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 152000000.00
CHD cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 152000000.00
CHD cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 413400000.00
CHD income_statement (annual, 2022-12-31) — Basic Average Shares: 242900000.00
CHD income_statement (annual, 2022-12-31) — Basic EPS: 1.70
CHD cash_flow (annual, 2022-12-31) — Beginning Cash Position: 240600000.00
CHD balance_sheet (annual, 2022-12-31) — Buildings And Improvements: 299100000.00
CHD cash_flow (annual, 2022-12-31) — Capital Expenditure: -178800000.00
CHD balance_sheet (annual, 2022-12-31) — Capital Stock: 293700000.00
CHD balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 270300000.00
CHD balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 270300000.00
CHD cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -255000000.00
CHD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: -120900000.00
CHD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -728600000.00
CHD cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 885200000.00
CHD cash_flow (annual, 2022-12-31) — Change In Account Payable: 6900000.00
CHD cash_flow (annual, 2022-12-31) — Change In Accrued Expense: 33000000.00
CHD cash_flow (annual, 2022-12-31) — Change In Income Tax Payable: 14400000.00
CHD cash_flow (annual, 2022-12-31) — Change In Inventory: -92800000.00
CHD cash_flow (annual, 2022-12-31) — Change In Other Current Assets: 2500000.00
CHD cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -27600000.00
CHD cash_flow (annual, 2022-12-31) — Change In Payable: 21300000.00
CHD cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 54300000.00
CHD cash_flow (annual, 2022-12-31) — Change In Receivables: -5300000.00
CHD cash_flow (annual, 2022-12-31) — Change In Tax Payable: 14400000.00
CHD cash_flow (annual, 2022-12-31) — Change In Working Capital: -68900000.00
CHD cash_flow (annual, 2022-12-31) — Changes In Account Receivables: -5300000.00
CHD cash_flow (annual, 2022-12-31) — Changes In Cash: 35700000.00
CHD balance_sheet (annual, 2022-12-31) — Commercial Paper: 70600000.00
CHD balance_sheet (annual, 2022-12-31) — Common Stock: 293700000.00
CHD cash_flow (annual, 2022-12-31) — Common Stock Dividend Paid: -255000000.00
CHD balance_sheet (annual, 2022-12-31) — Common Stock Equity: 3489900000.00
CHD cash_flow (annual, 2022-12-31) — Common Stock Payments: 0.00
CHD balance_sheet (annual, 2022-12-31) — Construction In Progress: 211500000.00
CHD income_statement (annual, 2022-12-31) — Cost Of Revenue: 3125600000.00
CHD balance_sheet (annual, 2022-12-31) — Current Accrued Expenses: 436100000.00
CHD balance_sheet (annual, 2022-12-31) — Current Assets: 1395900000.00
CHD balance_sheet (annual, 2022-12-31) — Current Debt: 74000000.00
CHD balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 74000000.00
CHD balance_sheet (annual, 2022-12-31) — Current Liabilities: 1183800000.00
CHD cash_flow (annual, 2022-12-31) — Deferred Income Tax: -117700000.00
CHD cash_flow (annual, 2022-12-31) — Deferred Tax: -117700000.00
CHD cash_flow (annual, 2022-12-31) — Depreciation: 67000000.00
CHD cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 219000000.00
CHD cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 219000000.00
CHD income_statement (annual, 2022-12-31) — Diluted Average Shares: 246300000.00
CHD income_statement (annual, 2022-12-31) — Diluted EPS: 1.68
CHD income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 413900000.00
CHD cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 8700000.00
CHD income_statement (annual, 2022-12-31) — EBIT: 612900000.00
CHD income_statement (annual, 2022-12-31) — EBITDA: 831900000.00
CHD income_statement (annual, 2022-12-31) — Earnings From Equity Interest: 12300000.00
CHD cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: -12300000.00
CHD cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: -6000000.00
CHD cash_flow (annual, 2022-12-31) — End Cash Position: 270300000.00
CHD cash_flow (annual, 2022-12-31) — Financing Cash Flow: -120900000.00
CHD balance_sheet (annual, 2022-12-31) — Finished Goods: 450300000.00
CHD balance_sheet (annual, 2022-12-31) — Foreign Currency Translation Adjustments: -46400000.00
CHD cash_flow (annual, 2022-12-31) — Free Cash Flow: 706400000.00
CHD income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 3800000.00
CHD balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -29300000.00
CHD income_statement (annual, 2022-12-31) — General And Administrative Expense: 706000000.00
CHD balance_sheet (annual, 2022-12-31) — Goodwill: 2426800000.00
CHD balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 5858400000.00
CHD balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 425500000.00
CHD balance_sheet (annual, 2022-12-31) — Gross PPE: 1601200000.00
CHD income_statement (annual, 2022-12-31) — Gross Profit: 2250000000.00
CHD income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 411000000.00
CHD cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 213100000.00
CHD balance_sheet (annual, 2022-12-31) — Income Tax Payable: 7000000.00
CHD income_statement (annual, 2022-12-31) — Interest Expense: 89600000.00
CHD income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 89600000.00
CHD income_statement (annual, 2022-12-31) — Interest Income: 3800000.00
CHD income_statement (annual, 2022-12-31) — Interest Income Non Operating: 3800000.00
CHD cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 86000000.00
CHD balance_sheet (annual, 2022-12-31) — Inventory: 646600000.00
CHD balance_sheet (annual, 2022-12-31) — Invested Capital: 6163400000.00
CHD cash_flow (annual, 2022-12-31) — Investing Cash Flow: -728600000.00
CHD balance_sheet (annual, 2022-12-31) — Investments And Advances: 12700000.00
CHD cash_flow (annual, 2022-12-31) — Issuance Of Debt: 998800000.00
CHD balance_sheet (annual, 2022-12-31) — Land And Improvements: 28100000.00
CHD balance_sheet (annual, 2022-12-31) — Line Of Credit: 3400000.00
CHD balance_sheet (annual, 2022-12-31) — Long Term Debt: 2599500000.00
CHD balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 2599500000.00
CHD cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 998800000.00
CHD cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -700000000.00
CHD balance_sheet (annual, 2022-12-31) — Long Term Equity Investment: 12700000.00
CHD balance_sheet (annual, 2022-12-31) — Machinery Furniture Equipment: 1062500000.00
CHD balance_sheet (annual, 2022-12-31) — Minimum Pension Liabilities: 1700000.00
CHD cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: -546800000.00
CHD cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CHD balance_sheet (annual, 2022-12-31) — Net Debt: 2403200000.00
CHD income_statement (annual, 2022-12-31) — Net Income: 413900000.00
CHD income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 413900000.00
CHD income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 413900000.00
CHD income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 413900000.00
CHD income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 413900000.00
CHD cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 413900000.00
CHD income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 413900000.00
CHD income_statement (annual, 2022-12-31) — Net Interest Income: -85800000.00
CHD cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 119900000.00
CHD cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 298800000.00
CHD income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -85800000.00
CHD cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -12000000.00
CHD cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -3000000.00
CHD balance_sheet (annual, 2022-12-31) — Net PPE: 761100000.00
CHD cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -178800000.00
CHD cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: -178900000.00
CHD balance_sheet (annual, 2022-12-31) — Net Tangible Assets: -2368500000.00
CHD balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 757000000.00
CHD balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 757000000.00
CHD income_statement (annual, 2022-12-31) — Normalized EBITDA: 1242900000.00
CHD income_statement (annual, 2022-12-31) — Normalized Income: 739001000.00
CHD cash_flow (annual, 2022-12-31) — Operating Cash Flow: 885200000.00
CHD cash_flow (annual, 2022-12-31) — Operating Gains Losses: -12300000.00
CHD income_statement (annual, 2022-12-31) — Operating Income: 1008800000.00
CHD income_statement (annual, 2022-12-31) — Operating Revenue: 5375600000.00
CHD balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 243895876.00
CHD balance_sheet (annual, 2022-12-31) — Other Current Assets: 57000000.00
CHD balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -29300000.00
CHD income_statement (annual, 2022-12-31) — Other Gand A: 706000000.00
CHD income_statement (annual, 2022-12-31) — Other Income Expense: -399700000.00
CHD balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 3431600000.00
CHD cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3200000.00
CHD balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 317500000.00
CHD balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 315400000.00
CHD income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -1000000.00
CHD balance_sheet (annual, 2022-12-31) — Payables: 673700000.00
CHD balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1109800000.00
CHD balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CHD income_statement (annual, 2022-12-31) — Pretax Income: 523300000.00
CHD cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 26200000.00
CHD balance_sheet (annual, 2022-12-31) — Properties: 0.00
CHD cash_flow (annual, 2022-12-31) — Purchase Of Business: -546800000.00
CHD cash_flow (annual, 2022-12-31) — Purchase Of PPE: -178800000.00
CHD balance_sheet (annual, 2022-12-31) — Raw Materials: 149500000.00
CHD balance_sheet (annual, 2022-12-31) — Receivables: 422000000.00
CHD income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 3125600000.00
CHD income_statement (annual, 2022-12-31) — Reconciled Depreciation: 219000000.00
CHD cash_flow (annual, 2022-12-31) — Repayment Of Debt: -878900000.00
CHD cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
CHD balance_sheet (annual, 2022-12-31) — Retained Earnings: 5524600000.00
CHD cash_flow (annual, 2022-12-31) — Sale Of Business: 0.00
CHD income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 535200000.00
CHD income_statement (annual, 2022-12-31) — Selling General And Administration: 1241200000.00
CHD balance_sheet (annual, 2022-12-31) — Share Issued: 293709982.00
CHD cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -178900000.00
CHD income_statement (annual, 2022-12-31) — Special Income Charges: -411000000.00
CHD cash_flow (annual, 2022-12-31) — Stock Based Compensation: 32300000.00
CHD balance_sheet (annual, 2022-12-31) — Stockholders Equity: 3489900000.00
CHD balance_sheet (annual, 2022-12-31) — Tangible Book Value: -2368500000.00
CHD income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: -85899000.00
CHD income_statement (annual, 2022-12-31) — Tax Provision: 109400000.00
CHD income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.21
CHD balance_sheet (annual, 2022-12-31) — Total Assets: 8345600000.00
CHD balance_sheet (annual, 2022-12-31) — Total Capitalization: 6089400000.00
CHD balance_sheet (annual, 2022-12-31) — Total Debt: 2673500000.00
CHD balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 3489900000.00
CHD income_statement (annual, 2022-12-31) — Total Expenses: 4366800000.00
CHD balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 4855700000.00
CHD balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 6949700000.00
CHD balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 3671900000.00
CHD income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 597800000.00
CHD balance_sheet (annual, 2022-12-31) — Total Tax Payable: 7000000.00
CHD income_statement (annual, 2022-12-31) — Total Unusual Items: -411000000.00
CHD income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: -411000000.00
CHD balance_sheet (annual, 2022-12-31) — Treasury Shares Number: 49814106.00
CHD balance_sheet (annual, 2022-12-31) — Treasury Stock: 2665300000.00
CHD balance_sheet (annual, 2022-12-31) — Work In Process: 46800000.00
CHD balance_sheet (annual, 2022-12-31) — Working Capital: 212100000.00
CHD income_statement (annual, 2023-12-31) — +Operating Expense: 1531100000.00
CHD income_statement (annual, 2023-12-31) — +Total Revenue: 5867900000.00
CHD balance_sheet (annual, 2023-12-31) — Accounts Payable: 630600000.00
CHD balance_sheet (annual, 2023-12-31) — Accounts Receivable: 526900000.00
CHD balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -889700000.00
CHD balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 454800000.00
CHD balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -7300000.00
CHD cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 152400000.00
CHD cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 152400000.00
CHD cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 8900000.00
CHD income_statement (annual, 2023-12-31) — Basic Average Shares: 244900000.00
CHD income_statement (annual, 2023-12-31) — Basic EPS: 3.09
CHD cash_flow (annual, 2023-12-31) — Beginning Cash Position: 270300000.00
CHD balance_sheet (annual, 2023-12-31) — Buildings And Improvements: 317800000.00
CHD cash_flow (annual, 2023-12-31) — Capital Expenditure: -223500000.00
CHD balance_sheet (annual, 2023-12-31) — Capital Stock: 293700000.00
CHD balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 344500000.00
CHD balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 344500000.00
CHD cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -266500000.00
CHD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: -725600000.00
CHD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -234300000.00
CHD cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 1030600000.00
CHD cash_flow (annual, 2023-12-31) — Change In Account Payable: -58100000.00
CHD cash_flow (annual, 2023-12-31) — Change In Accrued Expense: 113300000.00
CHD cash_flow (annual, 2023-12-31) — Change In Income Tax Payable: -1800000.00
CHD cash_flow (annual, 2023-12-31) — Change In Inventory: 38500000.00
CHD cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 10400000.00
CHD cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -14200000.00
CHD cash_flow (annual, 2023-12-31) — Change In Payable: -59900000.00
CHD cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 53400000.00
CHD cash_flow (annual, 2023-12-31) — Change In Receivables: -97400000.00
CHD cash_flow (annual, 2023-12-31) — Change In Tax Payable: -1800000.00
CHD cash_flow (annual, 2023-12-31) — Change In Working Capital: -9300000.00
CHD cash_flow (annual, 2023-12-31) — Changes In Account Receivables: -97400000.00
CHD cash_flow (annual, 2023-12-31) — Changes In Cash: 70700000.00
CHD balance_sheet (annual, 2023-12-31) — Commercial Paper: 0.00
CHD balance_sheet (annual, 2023-12-31) — Common Stock: 293700000.00
CHD cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -266500000.00
CHD balance_sheet (annual, 2023-12-31) — Common Stock Equity: 3855400000.00
CHD cash_flow (annual, 2023-12-31) — Common Stock Payments: -300100000.00
CHD balance_sheet (annual, 2023-12-31) — Construction In Progress: 348400000.00
CHD income_statement (annual, 2023-12-31) — Cost Of Revenue: 3279400000.00
CHD balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 580400000.00
CHD balance_sheet (annual, 2023-12-31) — Current Assets: 1529700000.00
CHD balance_sheet (annual, 2023-12-31) — Current Debt: 203800000.00
CHD balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 203800000.00
CHD balance_sheet (annual, 2023-12-31) — Current Liabilities: 1422000000.00
CHD cash_flow (annual, 2023-12-31) — Deferred Income Tax: -13800000.00
CHD cash_flow (annual, 2023-12-31) — Deferred Tax: -13800000.00
CHD cash_flow (annual, 2023-12-31) — Depreciation: 72800000.00
CHD cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 225200000.00
CHD cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 225200000.00
CHD income_statement (annual, 2023-12-31) — Diluted Average Shares: 247600000.00
CHD income_statement (annual, 2023-12-31) — Diluted EPS: 3.05
CHD income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 755600000.00
CHD cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 9500000.00
CHD income_statement (annual, 2023-12-31) — EBIT: 1078300000.00
CHD income_statement (annual, 2023-12-31) — EBITDA: 1303500000.00
CHD income_statement (annual, 2023-12-31) — Earnings From Equity Interest: 8700000.00
CHD cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: -8700000.00
CHD cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 3500000.00
CHD cash_flow (annual, 2023-12-31) — End Cash Position: 344500000.00
CHD cash_flow (annual, 2023-12-31) — Financing Cash Flow: -725600000.00
CHD balance_sheet (annual, 2023-12-31) — Finished Goods: 435600000.00
CHD balance_sheet (annual, 2023-12-31) — Foreign Currency Translation Adjustments: -37800000.00
CHD cash_flow (annual, 2023-12-31) — Free Cash Flow: 807100000.00
CHD cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 0.00
CHD balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -27200000.00
CHD income_statement (annual, 2023-12-31) — General And Administrative Expense: 889800000.00
CHD balance_sheet (annual, 2023-12-31) — Goodwill: 2431500000.00
CHD balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 5733800000.00
CHD balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 534200000.00
CHD balance_sheet (annual, 2023-12-31) — Gross PPE: 1817400000.00
CHD income_statement (annual, 2023-12-31) — Gross Profit: 2588500000.00
CHD income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 0.00
CHD cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 228200000.00
CHD balance_sheet (annual, 2023-12-31) — Income Tax Payable: 7200000.00
CHD income_statement (annual, 2023-12-31) — Interest Expense: 110900000.00
CHD income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 110900000.00
CHD income_statement (annual, 2023-12-31) — Interest Income: 13000000.00
CHD income_statement (annual, 2023-12-31) — Interest Income Non Operating: 13000000.00
CHD cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 111900000.00
CHD balance_sheet (annual, 2023-12-31) — Inventory: 613300000.00
CHD balance_sheet (annual, 2023-12-31) — Invested Capital: 6261400000.00
CHD cash_flow (annual, 2023-12-31) — Investing Cash Flow: -234300000.00
CHD balance_sheet (annual, 2023-12-31) — Investments And Advances: 12000000.00
CHD cash_flow (annual, 2023-12-31) — Issuance Of Debt: 0.00
CHD balance_sheet (annual, 2023-12-31) — Land And Improvements: 28300000.00
CHD balance_sheet (annual, 2023-12-31) — Line Of Credit: 3900000.00
CHD balance_sheet (annual, 2023-12-31) — Long Term Debt: 2202200000.00
CHD balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 2202200000.00
CHD cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 0.00
CHD cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -200000000.00
CHD balance_sheet (annual, 2023-12-31) — Long Term Equity Investment: 12000000.00
CHD balance_sheet (annual, 2023-12-31) — Machinery Furniture Equipment: 1122900000.00
CHD balance_sheet (annual, 2023-12-31) — Minimum Pension Liabilities: 4600000.00
CHD cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 0.00
CHD cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: -300100000.00
CHD balance_sheet (annual, 2023-12-31) — Net Debt: 2061500000.00
CHD income_statement (annual, 2023-12-31) — Net Income: 755600000.00
CHD income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 755600000.00
CHD income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 755600000.00
CHD income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 755600000.00
CHD income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 755600000.00
CHD cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 755600000.00
CHD income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 755600000.00
CHD income_statement (annual, 2023-12-31) — Net Interest Income: -97900000.00
CHD cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: -270600000.00
CHD cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: -200000000.00
CHD income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -97900000.00
CHD cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -100000.00
CHD cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -10800000.00
CHD balance_sheet (annual, 2023-12-31) — Net PPE: 927700000.00
CHD cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: -223500000.00
CHD cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -70600000.00
CHD balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -1878400000.00